<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Addict Med</journal-id><journal-id journal-id-type="iso-abbrev">J Addict Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of addiction medicine</journal-title></journal-title-group><issn pub-type="ppub">1932-0620</issn><issn pub-type="epub">1935-3227</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11790388</article-id><article-id pub-id-type="pmcid-ver">PMC11790388.1</article-id><article-id pub-id-type="pmcaid">11790388</article-id><article-id pub-id-type="pmcaiid">11790388</article-id><article-id pub-id-type="manuscript-id">NIHMS2026237</article-id><article-id pub-id-type="pmid">39230045</article-id><article-id pub-id-type="doi">10.1097/ADM.0000000000001372</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2026237</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2026237</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Medications for alcohol use disorder among birthing people with an alcohol-related diagnosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Roberts</surname><given-names initials="SCM">Sarah CM</given-names></name><degrees>DrPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="G">Guodong</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Terplan</surname><given-names initials="M">Mishka</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Advancing New Standards in Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 1330 Broadway, Suite 1100, Oakland, CA 94612</aff><aff id="A2"><label>2</label>Penn State College of Medicine, Department of Public Health Sciences and of Pediatrics, Hershey, PA, 17033</aff><aff id="A3"><label>3</label>Friends Research Institute, 1040 Park Ave, Suite 103, Baltimore, MD 21201</aff><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Sarah CM Roberts, DrPH; 1330 Broadway, Suite 1100; Oakland, CA 94612; <email>sarah.roberts@ucsf.edu</email></corresp><fn fn-type="COI-statement" id="FN1"><p id="P22"><bold>Conflicts of interest:</bold> None</p></fn></author-notes><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2025</year></pub-date><pub-date pub-type="epub"><day>04</day><month>9</month><year>2024</year></pub-date><volume>19</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">481175</issue-id><fpage>41</fpage><lpage>46</lpage><pub-history><event event-type="nihms-submitted"><date><day>09</day><month>10</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-11 17:25:20.443"><day>11</day><month>02</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2026237.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objectives:</title><p id="P1">Although safety and effectiveness of medications for alcohol use disorder (AUD) are well established for adults, literature on these medications in pregnancy is limited. Given known adverse effects of untreated AUD during pregnancy, clinicians and researchers have recently begun to call for reconsidering use of medications for AUD in pregnancy. Thus, we sought to estimate the proportion of birthing people with an alcohol-related diagnosis who received a prescription for medication related to AUD treatment.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">Data were from Meritive MarketScan<sup>&#174;</sup>, a national private insurance claims database. The study cohort included birthing people aged 25-50 who gave birth to a singleton in the U.S. between 2006 and 2019 and were matched with an infant. Variables included an alcohol-related diagnosis within a year of birth and receiving a prescription for a medication related to AUD treatment. We calculated proportions with alcohol-related diagnoses who received any AUD medication and each medication type.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Of 1,432,979 birthing person-infant dyads, 2,517 (0.18%) had an alcohol-related diagnosis. Of those with an alcohol-related diagnosis, 8.70% (n=219) received any medication. The most common was gabapentin (4.69%, n=118), with benzodiazepines for withdrawal as the second most common (2.19%, n=55). Approximately 2% received naltrexone (1.91%, n=48) and/or disulfiram (1.39%, n=35); 0.56% (n=14) received acamprosate. No one with an alcohol-related diagnosis received phenobarbital. Almost all medications were received postpartum.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Very few pregnant/postpartum people with alcohol-related diagnoses are prescribed medications related to AUD treatment. Research is needed to examine whether benefits of these medications during pregnancy outweigh harms.</p></sec></abstract><kwd-group><kwd>pregnancy</kwd><kwd>alcohol use disorder</kwd><kwd>treatment</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>